Table 8 Incremental cost-effectiveness ratio of HPV vaccination plus cervical cancer screening compared to cervical cancer screening alone: Incremental cost-effectiveness ratio of HPV vaccination with applying economies of scale and cervical cancer screening without taking into account economies of scale

10

20

30

40

50

60

70

80

90

100

10

− 30^a

120^b

270^b

440^b

600^b

770^b

940^b

1120^b

1300^b

1480^b

20

− 470^a

− 330^a

− 190^a

− 50^a

100^b

250^b

400^b

560^b

720^b

880^b

30

− 820^a

− 690^a

− 570^a

− 440^a

− 310^a

− 170^a

− 40^a

110^b

250^b

400^b

40

− 1140^a

− 1040^a

− 920^a

− 810^a

− 690^a

− 570^a

− 450^a

− 320^a

− 190^a

− 60^a

50

− 1460^a

− 1370^a

− 1270^a

− 1170^a

− 1060^a

− 960^a

− 850^a

− 740^a

− 620^a

− 510^a

60

− 1780^a

− 1700^a

− 1610^a

− 1520^a

− 1430^a

− 1340^a

− 1240^a

− 1150^a

− 1050^a

− 950^a

70

− 2090^a

− 2020^a

− 1950^a

− 1870^a

− 1800^a

− 1720^a

− 1640^a

− 1550^a

− 1470^a

− 1380^a

80

− 2410^a

− 2350^a

− 2290^a

− 2220^a

− 2160^a

− 2100^a

− 2030^a

− 1960^a

− 1890^a

− 1820^a

90

− 2720^a

− 2670^a

− 2620^a

− 2570^a

− 2520^a

− 2470^a

− 2420^a

− 2360^a

− 2310^a

− 2250^a

100

− 3030^a

− 2990^a

− 2960^a

− 2920^a

− 2880^a

− 2850^a

− 2810^a

− 2770^a

− 2720^a

− 2680^a